News From Law.com
A federal judge in New York dismissed an antitrust lawsuit that alleged four drug manufacturers manipulated the pricing of insulin products under a program intended to deliver low-cost medications to underserved patients was dismissed on Feb. 1.
Biotech & Pharmaceuticals
February 05, 2024, 3:27 PM